| Literature DB >> 30995934 |
Xiaoying Sun1, Xuerong Deng1, Wenhui Xie1, Liujun Wang1, Yu Wang1, Zhuoli Zhang2.
Abstract
BACKGROUND: Ultrasound (US) is sensitive for detecting joint and tendon inflammation in patients with rheumatoid arthritis (RA). So far, which grade of abnormalities on US corresponds to clinical manifestations is unclear. This study aimed to investigate the agreement between US-detected joint inflammation and clinical signs (joint swelling and tenderness).Entities:
Keywords: Peritendinitis; Rheumatoid arthritis; Swelling; Synovitis; Tenderness; Tenosynovitis; Ultrasound
Year: 2019 PMID: 30995934 PMCID: PMC6471966 DOI: 10.1186/s13075-019-1892-0
Source DB: PubMed Journal: Arthritis Res Ther ISSN: 1478-6354 Impact factor: 5.156
Demographics and clinical characteristics of 258 RA patients
| Parameters | Values |
|---|---|
| Age (years), mean ± SD | 51.23 ± 13.74 |
| Female, | 215 (83.33) |
| Disease duration(months), median (IQR) | 57 (14.75, 121.75) |
| Positive RF, | 165 (73.01) |
| Positive ACPA, | 153 (87.43) |
| TJC-22, median (IQR) | 3 (1.6) |
| SJC-22, median (IQR) | 2 (0.5) |
| ESR (mm/h), median (IQR) | 29 (16.49) |
| CRP (mg/L), median (IQR) | 9.24 (3.57, 27.60) |
| Patient’s global assessment (mm), median (IQR) | 50 (30, 70) |
| Evaluator’s global assessment (mm), median (IQR) | 40 (20, 60) |
| DAS28-ESR, mean ± SD | 4.47 ± 1.62 |
| DAS28-CRP, mean ± SD | 3.99 ± 1.51 |
| CDAI, median (IQR) | 14 (8, 24) |
| SDAI, median (IQR) | 15.38 (8.30, 26.83) |
| HAQ DI, median (IQR) | 0.40 (0.10, 0.90) |
| Individual of csDMARD use | |
| Methotrexate, | 160 (62.02) |
| Hydroxychloroquine, | 96 (37.21) |
| Leflunomide, | 70 (27.13) |
| Sulfasalazine, | 12 (4.65) |
| bDMARD use (%) | 12 (4.65) |
| Number of DMARDs | |
| 0, | 52 (20.16) |
| 1, | 84 (32.56) |
| 2, | 93 (36.05) |
| ≥ 3, | 29 (11.24) |
| Glucocorticoid use (%) | |
| Oral glucocorticoid use, | 41 (15.89) |
| Oral glucocorticoid dose (mg/day), median(IQR) | 10 (5.10) (prednisone equivalent) |
| Recent intramuscular injection of glucocorticoid (within 14 days), | 17 (6.59) |
| NSAIDs on demand, | 23 (8.91) |
Abbreviations: RF rheumatoid factor, ACPA anti-citrullinated peptide antibody, TJC-22 tender joint count in bilateral wrists, MCPs and PIPs joints, SJC-22 swollen joint count in bilateral wrists, MCPs and PIPs joints, ESR erythrocyte sedimentation rate, CRP C-reactive protein, DAS28-ESR Disease Activity Score based on 28 joint count and ESR, DAS28-CRP Disease Activity Score based on 28 joint count and CRP, CDAI Clinical Disease Activity Index, SDAI Simplified Disease Activity Index, HAQ DI Health Assessment Questionnaire disability index, csDMARDs conventional synthetic disease-modified anti-rheumatic drugs, bDMARD biological disease-modified anti-rheumatic drugs, NSAIDs non-steroidal anti-inflammatory drugs
Frequencies of PE detected tenderness or swelling and US-detected inflammation in wrist and finger joints
| Joints | PE detected tenderness or swelling (%) | US-detected inflammation (%) | |||
|---|---|---|---|---|---|
| Tenderness | Swelling | GS synovial hyperplasia | PD synovitis | Tenosynovitis/peritendinitis | |
| MCP1 | 19.38 | 11.67 | 12.92 | 6.25 | 0.00 |
| MCP2 | 24.79 | 22.29 | 20.21 | 13.96 | 0.00 |
| MCP3 | 19.58 | 17.71 | 15.83 | 10.63 | 1.16 |
| MCP4 | 13.13 | 11.04 | 10.00 | 6.88 | 0.58 |
| MCP5 | 15.42 | 12.71 | 13.54 | 6.88 | 0.19 |
| PIP1 | 20.63 | 13.75 | 3.54 | 1.46 | 0.39 |
| PIP2 | 27.50 | 20.63 | 3.13 | 1.04 | 1.16 |
| PIP3 | 32.50 | 22.29 | 7.50 | 3.13 | 2.32 |
| PIP4 | 25.00 | 16.67 | 5.83 | 2.92 | 1.35 |
| PIP5 | 22.92 | 16.88 | 3.96 | 1.46 | 0.58 |
| Wrist | 49.17 | 36.04 | 66.46 | 43.75 | 13.37 |
| At joint level | 22.83 | 17.05 | 14.11 | 8.39 | NA |
| At patient level | 84.11 | 74.03 | 85.27 | 62.01 | 25.97 |
Abbreviations: GS gray scale, PD power Doppler, MCP metacarpophalangeal, PIP proximal interphalangeal, PE physical examination, US ultrasound, NA not applicable
Fig. 1Various grades of GS synovial hyperplasia and PD synovitis, as a proportion of all findings. a Grade 1, grade 2, and grade 3 GS synovial hyperplasia, as a proportion of all findings for MCP1–5, PIP1–5 and wrist joints. b Grade 1, grade 2, and grade 3 PD synovitis, as a proportion of all findings for MCP1–5, PIP1–5, and wrist joints. Abbreviations: GS gray scale, PD power Doppler, MCP metacarpophalangeal, PIP proximal interphalangeal
The agreement between clinical findings and ultrasound detected inflammation, for wrist and finger joints
| Joint | Number of joints | Agreement (%) | Kappa | |||
|---|---|---|---|---|---|---|
| PE+/US+ | PE+/US− | PE−/US+ | PE−/US− | |||
| MCP1 | 37 | 69 | 25 | 385 | 81.78% | 0.340* |
| MCP2 | 71 | 81 | 30 | 334 | 78.49% | 0.426* |
| MCP3 | 58 | 70 | 21 | 367 | 82.36% | 0.458* |
| MCP4 | 30 | 50 | 22 | 414 | 86.05% | 0.379* |
| MCP5 | 39 | 54 | 28 | 395 | 84.11% | 0.396* |
| PIP1 | 17 | 96 | 4 | 399 | 80.62% | 0.199* |
| PIP2 | 15 | 137 | 7 | 357 | 72.09% | 0.106* |
| PIP3 | 38 | 138 | 10 | 330 | 71.32% | 0.226* |
| PIP4 | 26 | 108 | 9 | 373 | 77.33% | 0.224* |
| PIP5 | 16 | 114 | 6 | 380 | 76.74% | 0.148* |
| Wrist | 237 | 41 | 107 | 131 | 71.32% | 0.411* |
| Total | 584 | 958 | 269 | 3865 | 78.38% | 0.365* |
Abbreviations: MCP metacarpophalangeal, PIP proximal interphalangeal, PE+ presence of tenderness or swelling by physical examination, US+ GS ≥ 1 or PD ≥ 1 for synovitis or tenosynovitis/peritendinitis
*p < 0.01
Fig. 2Concordance (κ coefficient) between joint tenderness or swelling by PE and US-determined inflammation for each joint. Abbreviations: MCP metacarpophalangeal, PIP proximal interphalangeal
Fig. 3Concordance (κ coefficient) between tender or swollen joint and GS/PD grades for each joint region. a κ coefficient between tenderness and GS grade. b κ coefficient between swelling and GS grade. c κ coefficient between tenderness and PD grade. d κ coefficient between swelling and PD grade. Abbreviations: GS gray scale, PD power Doppler, MCP metacarpophalangeal, PIP proximal interphalangeal